Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 385K - 385K
Notice Type:
Contract award notice
Published Date:
11 January 2017
Closing Date:
Location(s):
FR FRANCE
Description:

Médicaments sous autorisation temporaire d'utilisation (ATU).


Médicaments sous ATU

Médicaments sous autorisation temporaire d'utilisation (ATU).

Awarded to:
175000
ABBVIE, Rungis Cedex (FR)
175001
Actelion Pharmaceuticals, Paris (FR)
175002
Celgene, Paris-la-Défense (FR)
175003
Cevidra, Grasse (FR)
175004
Genzyme, Saint-Germain-en-Laye Cedex (FR)
175005
Idis Limited, Weybridge (FR)
57, 60
Inresa, Bartenheim (FR)
175007
Intsel Chimos, Saint-Cloud Cedex (FR)
175008
Meda Pharma, Paris (FR)
175009
MSD France, Courbevoie (FR)
175010
Novartis Pharma, Rueil-Malmaison Cedex (FR)
175011
Pfizer Groupe, Paris Cedex 14 (FR)
175012
Serb, Paris (FR)
Download full details as .pdf
The Buyer:
CHG de Saint-Brieuc
CPV Code(s):
33600000 - Pharmaceutical products